References: Ferri P, Barbieri E, Burattini S, Guescini M, D'Emilio A, Biagiotti L, Del Grande P, De Luca A, Stocchi V, Falcieri E. Expression and subcellular localization of myogenic regulatory factors during the differentiation of skeletal muscle C2C12 myoblasts. J. Cell Biochem. 2009 Oct 14.
Li D, Niu Z, Yu W, Qian Y, Wang Q, Li Q, Yi Z, Luo J, Wu X, Wang Y, Schwartz RJ, Liu M. SMYD1, the myogenic activator, is a direct target of serum response factor and myogenin. Nucleic Acids Res. 2009 Sep 25.
Lindon C, Albagli O, Pinset C, Montarras D. Cell density-dependent induction of endogenous myogenin (myf4) gene expression by Myf5. Dev Biol. 2001 Dec 15;240(2):574-84.
Wright WE, Dac-Korytko I, Farmer K. Monoclonal antimyogenin antibodies define epitopes outside the bHLH domain where binding interferes with protein-protein and protein-DNA interactions. Dev Genet. 1996;19(2):131-8. (F5D, WB)
Chakraborty T, Martin JF, Olson EN. Analysis of the oligomerization of myogenin and E2A products in vivo using a two-hybrid assay system. J Biol Chem. 1992 Sep 5;267(25):17498-501.
Martin JF, Li L, Olson EN. Repression of myogenin function by TGF-beta 1 is targeted at the basic helix-loop-helix motif and is independent of E2A products. J Biol Chem. 1992 Jun 5;267(16):10956-60.